Andrea Etrusco

No ORCID on file · 20 papers in corpus · active 2022-2026

Study types

  • review 8
  • article 5
  • other 4
  • meta-analysis 3

Condition tags

  • endometriosis 9
  • adenomyosis 7
  • infertility 7
  • mesh:D004715 6
  • dysmenorrhea 2
  • chronic_pelvic_pain 1
  • mesh:D017699 1
  • die_deep_infiltrating 1
  • disambig:endometritis 1
review 2026
Frontiers in reproductive health ·doi:10.3389/frph.2026.1760832

Adenomyosis is an estrogen-dependent uterine disorder increasingly recognized as a major cause of infertility and adverse obstetric outcomes, yet optimal medical preparation before embryo transfer (ET) remains uncertain. Adenomyotic lesions…

other 2026
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70991

OBJECTIVE: To evaluate whether junctional zone (JZ) adenomyosis adversely affects assisted reproductive technologies (ART) outcomes in infertile women undergoing their first single embryo transfer (SET) using donor oocytes. METHODS: This r…

meta-analysis 2026
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2025.105178

This systematic review and meta-analysis (CRD42024588171) compared the effectiveness of surgery followed by IVF/intracytoplasmic sperm injection (IVF/ICSI) with direct IVF/ICSI (i.e. without previous surgery) on the reproductive outcomes of…

meta-analysis 2026
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2025.11.008

OBJECTIVE: To systematically review and quantify the impact of adenomyosis on maternal, neonatal, and obstetric outcomes. DATA SOURCES: A comprehensive, unrestricted search was conducted in MEDLINE, Scopus, Embase, Literatura Latino-Americ…

other 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1571727

BACKGROUND: To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and…

review 2025
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70134

BACKGROUND: Hormone pre-treatment is still used before assisted reproductive technique (ART) in endometriotic women, but evidence supporting this recommendation is conflicting. OBJECTIVES: To evaluate whether hormone pre-treatment with gona…

review 2025
·doi:10.1016/j.ajog.2025.03.005
other 2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1626445

OBJECTIVE: Endometriosis is a multifactorial disease that affects mainly women of reproductive age. It is unclear whether each form of pelvic endometriosis is an independent entity and whether a spatial relationship between all three endome…

review 2025
Gynecologic and obstetric investigation ·doi:10.1159/000543836

BACKGROUND: Embryo implantation and early survival in a synchronized, receptive endometrium are critical for establishing a successful pregnancy, but uterine pathologies can present challenges to reproductive success by significantly impact…

review 2024
·doi:10.1159/000539931

BACKGROUND: Pelvic congestion syndrome (PCS) is a poorly understood condition that can be associated with chronic pelvic pain and could impact quality of life. The diagnosis is often made by exclusion of other causes of pelvic pain. OBJECTI…

article 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102500
other 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102524

In women with proven infertility and deep endometriosis (DE), optimal management is controversial. To date, there is no clear evidence on the association between infertility and different stages of rASRM, nor is there clear guidance from le…

article 2024
·doi:10.1136/ebnurs-2023-103780
article 2024
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2024.07.031

BACKGROUND: Endometriosis has been associated with sleep disorders, and hyperarousal appears to be involved in their pathogenesis; however, the presence of hyperarousal in the endometriosis population was never investigated. METHODS: We con…

meta-analysis 2024
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-024-01707-4

Women with endometriosis were deemed more prone to COVID-19 infection in some reports. Considering that endometriosis-related aberrant immune response, understanding how COVID-19 vaccination influences its clinical status is crucial. The ai…

review 2023
Journal of personalized medicine ·doi:10.3390/jpm13050716

Background: Adenomyosis and congenital uterine anomalies (CUAs) can compromise reproductive potential and may coexist in the same patient, especially in cases of infertility. This review (CRD42022382850) aims to evaluate the published cases…

review 2023
Drugs ·doi:10.1007/s40265-023-01957-7

Adenomyosis, characterized by the growth of endometrial tissue within the uterine wall, poses significant challenges in treatment. The literature primarily focuses on managing abnormal uterine bleeding (AUB) and dysmenorrhea, the main sympt…

article 2023
·doi:10.1016/j.rbmo.2023.103435
article 2023
·doi:10.1016/j.rbmo.2023.103434
review 2022
·doi:10.1080/01443615.2022.2153297

Luteinised unruptured follicle syndrome (LUFS) is a cause of infertility consisting in the unruptured of the dominant follicle after the LH-surge. In fact, during assisted reproductive treatments (ART) clomiphene citrate and letrozole are f…